Incretin secretion and serum DPP-IV activity in Korean patients with type 2 diabetes

Diabetes Research and Clinical Practice
Seung Jin HanDae Jung Kim

Abstract

We evaluated incretin secretion and dipeptidyl peptidase (DPP)-IV activity in Korean type 2 diabetic patients compared with non-diabetic subjects. Type 2 diabetic patients showed intact GLP-1 and total GIP levels similar to those in non-diabetic subjects. Serum DPP-IV activity was significantly higher in type 2 diabetic patients (p=0.022).

References

Jan 1, 1986·Diabetologia·M NauckW Creutzfeldt
Nov 14, 2006·Lancet·Kun-Ho YoonHo-Young Son
Feb 9, 2010·Biochemical and Biophysical Research Communications·Junji KozawaIichiro Shimomura

❮ Previous
Next ❯

Citations

Jun 12, 2012·Translational Research : the Journal of Laboratory and Clinical Medicine·Gabor Firneisz, Aniko Somogyi
Feb 15, 2013·Clinical Endocrinology·Tae Jung OhYoung Min Cho
Jan 6, 2015·European Journal of Clinical Investigation·Zahra Al-AissaGábor Firneisz
Sep 30, 2015·Journal of Diabetes Investigation·Young Min Cho
Sep 12, 2012·Clinical Science·Usha PanchapakesanCarol Pollock

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.